Skip to ContentSkip to Navigation
How to find us prof. dr. J.A. (Hans) Langendijk


A Decision Support Tool to Optimize Selection of Head and Neck Cancer Patients for Proton Therapy

A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis

A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial

Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome

Current practice in proton therapy delivery in adult cancer patients across Europe

Diaphragm-Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiation Therapy Treatment of Distal Esophageal Cancer

Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma

High DNMT1 Is Associated With Worse Local Control in Early-Stage Laryngeal Squamous Cell Carcinoma

Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients

Read more


Protonentherapie UMCG dit jaar toegepast bij 480 patiënten, verwachting niet gehaald

Online Platform Improves Proton Therapy Delivery

IBA launches the world's first online proton therapy platform

IBA lance Campus : la première plateforme en ligne de protonthérapie au monde

IBA launches the world’s first online proton therapy platform

Protonentherapie is soms zinvoller dan gewone bestraling

Highlights of 2019

Protonenbestraling voor longkankerpatiënten

Na succesvolle proef in Groningen: Longkankerpatienten krijgen voortaan protonenbestraling vergoed

Read more